<DOC>
	<DOCNO>NCT00790569</DOCNO>
	<brief_summary>RATIONALE : Varenicline , nicotine patch , nicotine gum help people stop smoking . It yet know whether varenicline effective nicotine patch give together nicotine gum help smoker quit smoke . PURPOSE : This randomized clinical trial study varenicline see well work compare nicotine patch give together nicotine gum help smoker methadone treatment program stop smoking .</brief_summary>
	<brief_title>Varenicline Nicotine Patch Nicotine Gum Helping Smokers Methadone Treatment Program Stop Smoking</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine whether varenicline , nicotine receptor partial agonist , lead high rate smoke cessation combination nicotine replacement therapy nicotine patch prescription plus ad libitum nicotine gum delivery methadone-maintained smoker . Secondary - To test effect treatment smoke urge , withdrawal symptom , reinforce effect smoke . - To test effect treatment methadone treatment outcome , include retention methadone maintenance , methadone dose change , continue use illicit drug measure urine toxicology . OUTLINE : This multicenter study . Patients stratify base gender level nicotine dependence . Patients randomize 1 3 intervention arm . At baseline , patient receive minimal behavioral intervention use 3-minute , simple smoke cessation counseling strategy , self-help manual , telephone quit-line number . - Arm I ( varenicline ) : Patients receive oral varenicline daily day 1-3 twice daily thereafter total 6 month comfortable level smoking abstinence reach . - Arm II ( placebo ) : Patients receive oral varenicline placebo daily day 1-3 twice daily thereafter total 6 month comfortable level smoking abstinence reach . - Arm III ( nicotine patch/gum ) : Patients receive nicotine patch , dose taper time total 26 week . Patients also receive nicotine gum quell breakthrough urge . Patients may stop treatment comfortable level smoking abstinence reach . Patients complete brief interview 10-15 minute 2 week monthly month 1-5 . They complete long interview 45 minute month 6 12 provide breath sample ( carbon monoxide monitoring ) urine sample ( cotinine test ) . NOTE : Smoking cessation may prevent certain smoking-related illness , include cancer . PROJECTED ACCRUAL : A total 602 patient ( 258 receive varenicline , 258 receive nicotine replacement therapy , 86 receive placebo ) accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Current regular cigarette smoker ( 10 cigarettes/day past 3 month ) Interested quit smoke Willing set quit date 7 day baseline assessment Participating 1 5 methadone maintenance treatment program across Rhode Island follow institution : Codac , Inc. ( two independent site ) Addiction Recovery Institute Center Treatment Recovery Discovery House Has receive methadone least past month PATIENT CHARACTERISTICS : Not pregnant nursing Negative pregnancy test English speaking Has telephone live close relative neighbor telephone Willing make methadone dose methadone maintenance treatment program urine toxicology available review Available study next 12 month Not suffer unstable medical condition would preclude use nicotine patch ( e.g. , unstable angina uncontrolled hypertension ) No active skin condition ( e.g. , psoriasis ) No history skin allergy No history suicide attempt Not work pilot , driver , operator heavy machinery PRIOR CONCURRENT THERAPY : See Disease Characteristics No concurrent insulin blood thinner No concurrent smokeless tobacco , nicotine replacement therapy , smoke cessation treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>bladder cancer</keyword>
	<keyword>cervical cancer</keyword>
	<keyword>esophageal cancer</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>renal cell carcinoma</keyword>
	<keyword>adult primary liver cancer</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>hypopharyngeal cancer</keyword>
	<keyword>laryngeal cancer</keyword>
	<keyword>lip oral cavity cancer</keyword>
	<keyword>nasopharyngeal cancer</keyword>
	<keyword>oropharyngeal cancer</keyword>
	<keyword>paranasal sinus nasal cavity cancer</keyword>
	<keyword>adult acute myeloid leukemia</keyword>
	<keyword>tobacco use disorder</keyword>
</DOC>